OQROGet OQRO Pro
Insider trade

Akebia Therapeutics (AKBA)Officer sold ~$30K

Steven Keith Burke, Officer at Akebia Therapeutics, sold ~$30K of Akebia Therapeutics shares.

~$30K
Approx. value · 22K sh @ $1.39
995K
Holds after · shares reported
Traded
Feb 2, 2026
Filed
Feb 4, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Jan 27, 2026Company filing · Form 8-K · Material agreement, New debtChanged a top executive or board member, and signed an important agreement (and 1 more item)“On January 28, 2026 (the “Effective Date”), the Company entered into an amended and restated executive severance agreement (the “Amended CEO Executive Severance Agreement”) with the Company’s President and Chief Executive Officer, John P. Butler.”
  3. Feb 2, 2026 · this disclosureInsiderOfficer sold ~$30K of AKBA shares in the open market

What came next

  1. Feb 2, 2026Insider · 6 peopleInsiders: 14 sales (~$871K)
  2. Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
  3. Mar 4, 2026Insider · First insider buy since Nov 2019CEO purchased ~$87K of AKBA shares in the open market
  4. Mar 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member
  5. May 7, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Akebia Therapeutics

OQRO holds no insider, Congress, fund or contract record for Akebia Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AKBA page.

Other recent filings by Steven Keith Burke, SVP, Chief Medical Officer

The full history of Steven Keith Burke, SVP, Chief Medical Officer is on the profile page.

How this filing works

Other disclosures at Akebia Therapeutics

Everything OQRO holds on this company is on its AKBA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data